Rhode Island

Life Science Opportunity Atlas

IP-backed formation diligence

InvestorClinical expert

Explore opportunities

Search by company name (Bolden, Pax, OncoLux, Nabsys), asset id, or title. Each card links to a full dossier with cited evidence.

Loading filters…

Tier Aip_monaghan_deep_rna_dx
Deep RNA transcriptomic ICU diagnostics (host + pathogen)

One blood draw, full transcriptome—faster pathogen ID than culture, with host splicing biomarkers.

RIH-owned deep RNA platform + NIGMS R35 + Brown RNA Center—physician-founder spinout before national blood-RNA Dx scale-up.

Patents: 4Stage: clinical translational ldt
US20220340972A1US20250034234A1EP4599084A1CN120344677AR35GM142638PMID 41697057
Open dossier
Research synthesis from public sources (NIH RePORTER, ClinicalTrials.gov, PubMed, USPTO, company press). Not investment advice, legal opinion, or clinical guidance. Verify cap tables, license chains, and trial status in data rooms before term sheets.